MedTrace Logo

Comparison of Efficacy on Healing, and Safety of Two Dressings Urgotul and TulleGras MS on Surgical Acute Wounds.

NCT02322710 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 208

Last updated 2022-03-21

Study results available
· View outcomes & findings →

Summary

Evaluation of non-inferiority on healing rates of two dressings Urgotul and TulleGras MS in the treatment of surgical acute wounds.

Conditions

  • Surgical Acute Wounds

Interventions

DEVICE

Urgotul: Low-adherent dressing

DEVICE

TulleGras M.S.: Vaseline gauze

Sponsors & Collaborators

  • Fovea

    collaborator OTHER

  • Mylan Inc.

    lead INDUSTRY

Principal Investigators

  • Roger LESAUNIER, MD · Mylan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02322710 on ClinicalTrials.gov